ES2181052T3 - Fenilacetamidas como inhibidores de la spla2. - Google Patents

Fenilacetamidas como inhibidores de la spla2.

Info

Publication number
ES2181052T3
ES2181052T3 ES97952228T ES97952228T ES2181052T3 ES 2181052 T3 ES2181052 T3 ES 2181052T3 ES 97952228 T ES97952228 T ES 97952228T ES 97952228 T ES97952228 T ES 97952228T ES 2181052 T3 ES2181052 T3 ES 2181052T3
Authority
ES
Spain
Prior art keywords
phenylacetamids
spla2
inhibitors
septi
phenylacetamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97952228T
Other languages
English (en)
Inventor
Theodore Goodson Jr
Richard W Harper
David K Herron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2181052T3 publication Critical patent/ES2181052T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA CLASE DE NUEVAS FENILACETAMIDAS ASI COMO AL USO DE ESTOS COMPUESTOS TRATANDOSE DE INHIBIR LA LIBERACION DE LOS ACIDOS GRASOS CON MEDIACION SPLA 2 DE FORMA QUE SE TRATEN LOS TRASTORNOS COMO, POR EJEMPLO, UN CHOQUE SEPTICO.
ES97952228T 1996-12-03 1997-11-25 Fenilacetamidas como inhibidores de la spla2. Expired - Lifetime ES2181052T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3250896P 1996-12-03 1996-12-03

Publications (1)

Publication Number Publication Date
ES2181052T3 true ES2181052T3 (es) 2003-02-16

Family

ID=21865299

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97952228T Expired - Lifetime ES2181052T3 (es) 1996-12-03 1997-11-25 Fenilacetamidas como inhibidores de la spla2.

Country Status (12)

Country Link
US (1) US6353128B1 (es)
EP (1) EP0946495B1 (es)
JP (1) JP2001505575A (es)
KR (1) KR20000069248A (es)
AU (1) AU5589298A (es)
BR (1) BR9713987A (es)
CA (1) CA2273995A1 (es)
DE (1) DE69714289T2 (es)
ES (1) ES2181052T3 (es)
HU (1) HUP9904172A2 (es)
IL (1) IL130200A0 (es)
WO (1) WO1998024756A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0102981A3 (en) 1998-03-31 2002-10-28 Shionogi & Co Pyrrolo[1,2-a]pyrazine derivatives and pharmaceutical compositions thereof
WO1999059999A1 (en) 1998-05-21 1999-11-25 Shionogi & Co., Ltd. PYRROLO[1,2-b]PYRIDAZINE DERIVATIVES HAVING sPLA2 INHIBITORY EFFECT
AU6004799A (en) 1998-10-14 2000-05-01 Shionogi & Co., Ltd. Remedies or preventives for ischemic reflow failure
FR2793791B1 (fr) * 1999-05-19 2002-01-25 Univ Paris 7 Denis Diderot Nouveaux composes inhibiteurs specifiques de phospholipases a2
AU6015600A (en) 1999-07-19 2001-02-05 Shionogi & Co., Ltd. Tricyclic compounds having spla2-inhibitory activities
US6673781B1 (en) 1999-08-02 2004-01-06 Shionogi & Co., Ltd. Tricyclic compounds having sPLA2-inhibitory activities
WO2001014378A1 (en) 1999-08-23 2001-03-01 Shionogi & Co., Ltd. PYRROLOTRIAZINE DERIVATIVES HAVING sPLA2-INHIBITORY ACTIVITIES
SE0000754D0 (sv) * 2000-03-07 2000-03-07 Amersham Pharm Biotech Ab Mass spectral peak identification
WO2002000621A1 (en) 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Compounds exhibiting x-type spla2 inhibiting effect
US6967200B2 (en) 2000-06-29 2005-11-22 Shionogi & Co., Ltd. Remedies for cirrhosis
TWI314457B (es) 2001-03-19 2009-09-11 Shionogi & Co
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
WO2015026990A2 (en) * 2013-08-20 2015-02-26 University Of Washington Through Its Center For Commercialization Novel and specific inhibitors of cytochrome p450 26 retinoic acid hydrolase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584246A (en) 1976-06-16 1981-02-11 Ici Ltd Carboxamidoesters
US4256758A (en) * 1979-06-11 1981-03-17 Merck & Co., Inc. 4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase
CA1274843A (en) 1984-05-18 1990-10-02 Yoshiharu Hayashi 2-nitro-5-(2'-chloro-4'- trifluoromethylphenoxy)phenylacetic ester, thioester and amide, process for preparation thereof, herbicidal composition, and method for destruction of undesirable weeds
DE3812768A1 (de) 1988-04-16 1989-10-26 Bayer Ag Halogensubstituierte phenoxybenzylverbindungen
EP0779271B1 (en) 1995-12-13 2001-08-01 Eli Lilly And Company Naphthyl acetamides as sPLA2 inhibitors

Also Published As

Publication number Publication date
WO1998024756A1 (en) 1998-06-11
EP0946495A1 (en) 1999-10-06
BR9713987A (pt) 2000-02-08
AU5589298A (en) 1998-06-29
EP0946495A4 (en) 2000-04-12
EP0946495B1 (en) 2002-07-24
CA2273995A1 (en) 1998-06-11
IL130200A0 (en) 2000-06-01
US6353128B1 (en) 2002-03-05
JP2001505575A (ja) 2001-04-24
DE69714289T2 (de) 2003-01-16
HUP9904172A2 (hu) 2000-05-28
DE69714289D1 (en) 2002-08-29
KR20000069248A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
ES2179088T3 (es) Inhibidores de flsa2 1h-indol-3-glioxilamida.
ES2181052T3 (es) Fenilacetamidas como inhibidores de la spla2.
BR9714002A (pt) Pirróis como inibidores de spla2
HN1997000079A (es) Analogos de indazol sustituido.
ES2162198T3 (es) Agentes estrogenos.
ES2174873T3 (es) Talidomina para inhibir la angiogenesis.
HN1997000072A (es) Procedimiento para la preparacion de sildenafil
EA199900301A2 (ru) Замещенные трициклические соединения
BR9713261A (pt) Tricìclicos substituìdos
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
ES2159347T3 (es) Naftil-acetamidas como inhibidores de spla2.
ES2195182T3 (es) Fenil glioxamidas como inhibidores de spla2.
SV1999000052A (es) Triciclicos substituidos ref. x-12144
DE69931496D1 (de) INDOLVERBINDUNGEN ALS sPLA2 INHIBITOREN
GR3031602T3 (en) Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase.
ES2174034T3 (es) Naftilglioxamidas como inhibidores de spla2
DE69910432D1 (de) Substituierte pyrroloindole
DE60032774D1 (de) Spla2 inhibitoren
ES2184192T3 (es) Procedimiento microbiologico para la transformacion de 3-oxo-4-azaesteroides 17beta-carboxisustituidos y uso de tales productos como inhibidores de la enzima 5alfa-reductasa.
ECSP982563A (es) Procedimiento para la preparacion de 4- sustituido -1h- indol -3-glioxamidas
AR013802A1 (es) Inhibidores de angiogenesis de triazina
HN1997000147A (es) Procedimientos para piridinas sustituidas
HN1997000073A (es) Compuestos inhibidores de la escualeno sintetasa